PharmAust Limited advises that Chief Scientific Officer of PharmAust Ltd. and Chief Executive Officer of PharmAust's fully owned subsidiary Pitney Pharmaceuticals Pty Ltd, Dr. Richard Mollard, has tendered his resignation and given the Company six months' notice as required under his contract. Dr. Mollard has been with PharmAust for five years and, during this time, he has played an important role in establishing and undertaking many activities on behalf of the Company. The Company will consider the optimal way to resource and undertake future steps in furtherance of the Company's different projects, and this may include identifying several resources for the different projects.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.235 AUD | +14.63% | +38.24% | +104.35% |
05-31 | PharmAust Reappoints CEO | MT |
05-17 | PharmAust Appoints Nonexecutive Chair; Shares Up 3% | MT |
1st Jan change | Capi. | |
---|---|---|
+104.35% | 53.95M | |
+42.69% | 750B | |
+34.11% | 606B | |
-6.87% | 356B | |
+18.74% | 326B | |
+6.76% | 286B | |
+18.08% | 246B | |
-3.44% | 213B | |
+11.35% | 213B | |
+2.64% | 167B |
- Stock Market
- Equities
- PAA Stock
- News PharmAust Limited
- PharmAust Limited Announces Resignation of Richard Mollard as Chief Scientific Officer